Short answer
MEDIFAST INC (MED) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 FY2026 earnings released August 3, 2026, covering the quarter ended June 30, 2026.
MEDIFAST INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 FY2026 earnings released August 3, 2026, covering the quarter ended June 30, 2026
- Detailed financial results and management commentary contained in Exhibit 99.1
- Earnings release furnished under Item 2.02, limiting its status as a filed disclosure
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $76.4M, down 27.6% year over year, reflecting continued demand pressure and rapid GLP-1 adoption
- Active earning coaches fell 48.7% to 11,700, while revenue per coach rose 41.0% to $6,529
- Net loss $3.1M, or $0.28 diluted EPS, versus $2.5M net income and $0.22 EPS last year
- Gross margin declined to 69.9% from 72.6%, while SG&A increased to 75.6% of revenue
- Cash and investments $169.8M with no debt, supporting the turnaround despite Q3 revenue guidance of $60M to $80M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MEDIFAST INC 8-K filings
Get the next MED 8-K as it lands
Follow MED for push alerts, or ask the research agent what this filing means.